Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | FOXO1 | Q12778 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 9/20 | 0.34 |
| ▸ | CNR2 | P34972 | 9/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1242841 | 0.88 | MEN1 (0.58) | MEN1KMT2AGAAFOXO1KDM4E | |
| SCHEMBL4098860 | 0.85 | MEN1 (0.53) | MEN1KMT2AGAAFOXO1KDM4E | |
| SCHEMBL1243323 | 0.83 | MEN1 (0.75) | MEN1KMT2AGAAFOXO1KDM4E | |
| SCHEMBL1243435 | 0.82 | MEN1 (0.52) | MEN1KMT2AGAAFOXO1KDM4E | |
| SCHEMBL1242761 | 0.82 | MEN1 (0.52) | MEN1KMT2AGAAFOXO1KDM4E | |
| SCHEMBL1242810 | 0.81 | MEN1 (0.51) | MEN1KMT2AGAAFOXO1KDM4E | |
| SCHEMBL1243135 | 0.80 | MEN1 (0.65) | MEN1KMT2AGAAFOXO1KDM4E | |
| SCHEMBL1241043 | 0.80 | MEN1 (0.54) | MEN1KMT2AGAAFOXO1KDM4E | |
| SCHEMBL27656201 | 0.80 | MEN1 (0.54) | MEN1KMT2AGAAFOXO1KDM4E | |
| SCHEMBL1243443 | 0.80 | MEN1 (0.49) | MEN1KMT2AGAAFOXO1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7879878-B2 | such as {2-[({[7-(cyclohexylamino)-6-fluoro-4-oxo-1-[(3S)-tetrahydrofuran-3-yl]-1,4-dihydroquinolin-3-yl}carbonyl)amino]ethyl}phosphonic acid, used as platelet aggregation inhibitor and purinergic receptor (P2Y12) inhibitors; therapy for circulatory diseases involving thrombosis via platelet aggregation | ASTELLAS PHARMA INC. (JP) | 2011-02-01 | — | — | US | disclosed |